Aiming to immune elimination of ovarian cancer stem cells

doi:10.4252/wjsc.v5.i4.149

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8664)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

460

HTML

5827

Figures (1-6)

422

Sum=6709

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

953

Download

1002

Sum=1955

Oct 26, 2013 (publication date) through Nov 13, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Oct 26, 2013; 5(4): 149-162
Published online Oct 26, 2013. doi: 10.4252/wjsc.v5.i4.149

Full Size Figure Download Figure

Figure 6 PD-1 and Tim-3 expression by ascitic lymphocytes from patients with ovarian cancer. PD-1 expression was undetectable in ascitic lymphocytes. Compare to isotype control, peripheral blood lymphocyte (PBL) from healthy express 2% Tim-3, ascitic CD4⁺ and CD8⁺ cells express four times more Tim-3 than control PBL.

Citation: Di J, Duiveman-de Boer T, Figdor CG, Torensma R. Aiming to immune elimination of ovarian cancer stem cells. World J Stem Cells 2013; 5(4): 149-162
URL: https://www.wjgnet.com/1948-0210/full/v5/i4/149.htm
DOI: https://dx.doi.org/10.4252/wjsc.v5.i4.149